Listen: Is 23andMe Trading Your DNA? With Maria Liu from First Health Advisory Solutions

+ more

 

23andMe, the genetic testing company, just announced that it will be entering a 4-year partnership with pharmaceutical giant GlaxoSmithKline (GSK) to develop new drugs and therapies.

As part of the partnership, 23andMe will share voluntarily-shared genetic data with the big pharma company. Maria Liu from First Health Advisory Solutions joined us to talk about the security concerns and potential worries that come with companies sharing medical data.

For the latest news, videos, and podcasts in the Healthcare Industry, be sure to subscribe to our industry publication.

Follow us on social media for the latest updates in B2B!
Twitter – @HealthMKSL
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Latest

Is Facebook’s Reputation Holding Back Its VR Efforts?
August 4, 2021
Whether you’re an integrator, a designer or simply a label-defying creative, the EXPERIENCE is everything. Host Bryan Meszaros explores the story behind the exhibit to understand how a carefully crafted experience Read more
How Is the Biden Admin’s Attack on Anti-Competitive Policies Shaping Agriculture?
August 4, 2021
The Biden administration has set its sights firmly on breaking down anti-competitive practices across a wide range of industries, and the nation’s agricultural sector is beginning to feel the Read more
How Will Airlines Keep Up The Momentum With an Uptick In Travel? 
August 4, 2021
"Really key in on that opportunity for the folks that have children to make it a really fun experience for the kids." With the economy opening back up, things are looking good for airlines. In late July, Read more